Lipe & Dalton Increases Position in Bristol-Myers Squibb Co (BMY)

The institutional investor owned 15,230 shares of the biopharmaceutical company's stock after buying an additional 1,987 shares during the quarter. The overall volume in the last trading session was 5.09 million shares. Its share price has decline -4.79% in three months and is up 1.06% for the last five trades. It has underperformed by 1.43% the S&P500. Tradewinds Capital Management LLC now owns 1,945 shares of the biopharmaceutical company's stock valued at $108,000 after purchasing an additional 500 shares in the last quarter. The institutional investor held 12,850 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $819,000, down from 41,102 at the end of the previous reported quarter. Duncker Streett stated it has 0.27% in The Sherwin-Williams Company (NYSE:SHW). Whereas the traders who further want to see about this, may be interested to see Price to next year's EPS that would be 5.43%.

OLD Republic International Corp trimmed its stake in Bristol-Myers Squibb Co (NYSE:BMY) by 16.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. It has underperformed by 39.89% the S&P500.

Investors sentiment decreased to 1.02 in Q3 2017. Its down 0.53, from 1.75 in 2017Q2. Earnest Partners stated it has 1.15 million shares or 0.66% of all its holdings. 80 funds opened positions while 247 raised stakes. 300 were accumulated by Clearbridge Invs Ltd. Suffolk Mgmt Ltd Liability Co, a New York-based fund reported 34,342 shares. Credit Agricole S A has 0.01% invested in First Solar, Inc. Barclays Plc, a United Kingdom-based fund reported 17 shares. Stevens Cap Management LP reported 0.04% of its portfolio in Noble Energy, Inc. (NYSE:VMI). Shell Asset Management Comm has invested 0.02% of its portfolio in Valmont Industries, Inc. Spark Investment Management Llc owns 48,700 shares or 0.01% of their U.S. portfolio.

Cmt Asset Management Ltd, which manages about $2.08 billion US Long portfolio, upped its stake in Merck & Co Inc (Call) by 73,600 shares to 103,000 shares, valued at $6.59 million in 2017Q3, according to the filing. Atlantic Group holds 0.12% or 412,660 shares in its portfolio. Creative Planning holds 0.01% of its portfolio in The Sherwin-Williams Company (NYSE:SHW) for 6,735 shares. Colony Gp Inc Ltd Llc has invested 0.09% in Noble Energy, Inc. Hap Trading Lc reported 63,358 shares or 1.08% of all its holdings.

Since September 6, 2017, it had 1 buying transaction, and 2 sales for $646,385 activity.

In related news, EVP Thomas J. Jr. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Therefore 50% are positive. Airboss Of America Corp. had 10 analyst reports since August 13, 2015 according to SRatingsIntel. Jefferies maintained the shares of BMY in report on Thursday, November 16 with "Hold" rating. As per Tuesday, September 29, the company rating was upgraded by UBS. As per Thursday, November 5, the company rating was maintained by Argus Research. (NYSE:VMI) on Thursday, July 20 with "Hold" rating. (NYSE:NBL) on Monday, May 8 with "Overweight" rating. The stock has "Outperform" rating by Robert W. Baird on Wednesday, April 26. The rating was maintained by Citigroup on Wednesday, October 25 with "Buy". The rating was maintained by TD Securities with "Buy" on Friday, March 3. The firm has "Sell" rating by Seaport Global given on Friday, December 9. Its up 0.08, from 0.95 in 2017Q2. It increased, as 62 investors sold BMY shares while 519 reduced holdings. American National Bank raised its stake in shares of Bristol-Myers Squibb by 11.7% in the 2nd quarter. Comerica holds 5,359 shares or 0.05% of its portfolio. 506,273 were reported by Grp Incorporated. Employees Retirement System Of Ohio owns 35,198 shares. 10,595 were reported by Foster Dykema Cabot Ma. FDx Advisors Inc. lifted its position in shares of Bristol-Myers Squibb by 3.2% during the 3rd quarter.

Bristol-Myers Squibb Company (BMY) in the last quarter reported its actual EPS of $0.75/share where the analyst estimated EPS was $0.77/share. Garrison Bradford Associate has invested 0.21% in Bristol-Myers Squibb Company (NYSE:BMY). Caisse De Depot Et Placement Du Quebec holds 0.08% or 569,774 shares in its portfolio. Vanguard Group Inc. boosted its position in Bristol-Myers Squibb Company by 3.4% in the second quarter. Bollard Group holds 191,635 shares.

Raub Brock Capital Management Lp increased its stake in Sherwin (SHW) by 5.72% based on its latest 2017Q3 regulatory filing with the SEC. Cullinan Assoc reported 128,196 shares. Therefore 32% are positive. Bristol-Myers Squibb's revenue for the quarter was up 6.7% on a year-over-year basis. equities research analysts anticipate that Bristol-Myers Squibb Co will post 2.99 earnings per share for the current year. The company's stock had a trading volume of 10,933,979 shares. The firm has "Hold" rating by Hilliard Lyons given on Tuesday, September 12. On Thursday, July 20 the stock rating was maintained by Stifel Nicolaus with "Buy". The stock of Bristol-Myers Squibb Company (NYSE:BMY) has "Sell" rating given on Monday, June 5 by BMO Capital Markets. Credit Suisse maintained the shares of BMY in report on Friday, October 27 with "Neutral" rating. Leerink Swann reiterated an "outperform" rating and set a $62.00 price objective on shares of Bristol-Myers Squibb Company in a research report on Monday, January 30th. Deutsche Bank has "Hold" rating and $52 target. Wells Fargo initiated the shares of SHW in report on Thursday, September 29 with "Market Perform" rating.